Abstract
With the increasing number of patients affected with metabolic diseases such as type 2 diabetes, obesity, atherosclerosis and insulin resistance, academic researchers and pharmaceutical companies are eager to better understand metabolic syndrome and develop new drugs for its treatment. Many studies have focused on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ), which plays a crucial role in adipogenesis and lipid metabolism. These studies have been able to connect this transcription factor to several human metabolic diseases. Due to obvious limitations concerning experimentation in humans, animal models—mainly mouse models-have been generated to investigate the role of PPARγ in different tissues. This review focuses on the metabolic features of human and mouse PPARγ -related diseases and the utility of the mouse as a model.
| Original language | English (US) |
|---|---|
| Article number | 1236 |
| Journal | International journal of molecular sciences |
| Volume | 17 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2016 |
| Externally published | Yes |
Keywords
- Human mutations
- Ligand activation
- Lipodystrophy
- Metabolic syndrome
- Mouse models
- PPARγ expression
ASJC Scopus subject areas
- Catalysis
- Molecular Biology
- Spectroscopy
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry
- Inorganic Chemistry